Synthesis and Anxiolytic Activity of 2- (Substituted)-5-[(N-Benzotriazolomethyl)-1,3, 4-Thiadiazolyl]-4-Thiazolidinone

Abstract

1,2,3- Benzotriazole (BTA) is a heterocyclic compound with three nitrogen atoms. It is a polar and colourless compound which can be used for its great versatility. The enormous investigations on derivatives of benzotriazole reveal wide applicability of this molecule for tagging and delivering huge number of heterocyclic nuclei. In the present work synthesis of several derivatives of 2-(substituted)-5-[(n-benzotriazolomethyl)-1,3,4-thiadiazolyl]-4-thiazolidinone has been synthesized and are evaluated for their anxiolytic activity. The antianxiety activities of the synthesized derivatives were evaluated using EPM test and Bright and dark box test experimental models of anxiety. All results were expressed as meanĀ± standard error mean (SEM) and analysed by one-way ANOVA. Post-hoc comparisons were performed by applying Dunnefs test. P <0.05 was considered statistically significant 1,2,3- benzotriazoles were reported to have potential fungicidal [1] and antibacterial activity [2]. Similarly 1,3,4-thiadiazole derivatives were also reported to possess fungicidal, herbicidal, bactericidal [3], pesticidal, insecticidal, antihistaminic, antiamoebic [4], CNS depressant, antihypertensive, anticonvulsant, hypnotic, analgesic [5], anti-inflammatory [6] and agonist for 5-Ht receptor [7]. 4-thiazolidinone nucleus has also occupied a unique place in the field of medicinal chemistry due to its wide range of biological activities like antibacterial, anticancer [8], Respiratory, syncytial, virus Inhibitor [9], anticonvulsant [10], sciatic nerve blocking, local anaesthetic, inhibitors of human (CK2) protein kinase [11], hypnotic, fungicidal, cysticidal, anti leukemic and antioxidant activity. In view of potential biological activities of benzotriazole, thiadiazole and 4-thiazolidinone an attempt has made to unite these nuclei together and synthesize some new derivatives of benzotriazole (X^XJ to probe how far these combinations could develop anxiolytic activity. The procedure of synthesis has been outlined in Figure 1. Anxiety is a normal emotional response which when chronic or severe becomes pathological and can aggravate cardiovascular and psychiatric disorders [12]. Despite the development of new molecules for pharmacotherapy of anxiety, the treatment is challenging as they produce various side effects or exhibit tolerance on continuous use.

Authors and Affiliations

V K Singh, Peeyush Bharadwaj, Poonam Rishishwar

Keywords

Related Articles

Intrinsically Disordered Proteins (IDPs): Experimental and Computational Approaches in Drug Discovery

Soluble proteins may consist of globular units and non-globular units. Globular units are composed of regular secondary structure elements whereas the non-globular units are composed of d...

A Review on The Phytochemical and Pharmacological Properties Barringtonia Asiatica

A review of Barringtonia asiatica considered to be a mangrove associated species is made to update its Phytochemical and Pharmacological Properties which is claimed to be a broad-spectrum medicinal property. Barringtonia...

Nutrigenomics: Opportunities and Challenges in Bangladesh

The Authors of this article has been working on ethnopharmacology and natural product science for the last one decade. They have been involved with several ethnic and traditional medication system development projects an...

Development of Some Eco-Efficient and Selective Chemical Processes and Products Using Sustainable and Green Chemistry Approaches

Historical records show that scientific advancements accounted for substantial changes in our life-style and wellbeing. The Industrial Revolution took place in the western countries in the 1700s when people first appreci...

Beyond Pain, Fear, Withdrawal-Findings, And Problems Involving Change - Treatment and Application for A Chronic Addiction on Alcohol Do Not End

Alcohol use disorders (AUD) involving hazardous, harmful and addictive misuse of alcohol are widespread in most parts of the world. The aim of this study was to review the effect of the common inhibitors in the treatment...

Download PDF file
  • EP ID EP585675
  • DOI 10.32474/DDIPIJ.2018.01.000104
  • Views 203
  • Downloads 0

How To Cite

V K Singh, Peeyush Bharadwaj, Poonam Rishishwar (2018). Synthesis and Anxiolytic Activity of 2- (Substituted)-5-[(N-Benzotriazolomethyl)-1,3, 4-Thiadiazolyl]-4-Thiazolidinone. Drug Designing & Intellectual Properties International Journal, 1(1), 16-21. https://europub.co.uk./articles/-A-585675